v3.26.1
Statements of Changes in Shareholders’ Deficit - USD ($)
Class A
Ordinary Shares
 [1]
Class B
Ordinary Shares
 [2]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Sep. 08, 2024
Balance (in Shares) at Sep. 08, 2024      
Issuance of Class B ordinary shares $ 1,207 23,793 25,000
Issuance of Class B ordinary shares (in shares) 12,075,000      
Issuance of Class A shares to non-executive director nominees $ 16 384 400
Issuance of Class A shares to non-executive director nominees (in Shares) 160,000      
Net income (loss) (57,191) (57,191)
Balance at Dec. 31, 2024 $ 16 $ 1,207 24,177 (57,191) (31,791)
Balance (in Shares) at Dec. 31, 2024 160,000 12,075,000      
Accretion for Class A ordinary shares to redemption amount (15,056,373) (25,242,046) (40,298,419)
Sale 787,857 of Private Placement Units $ 79 7,878,491 7,878,570
Sale 787,857 of Private Placement Units (in Shares) 787,857      
Fair Value of Public Warrants at issuance 7,590,000 7,590,000
Allocated value of transaction costs to Class A shares (436,353) (436,353)
Forfeiture of Founder Shares $ (58) 58
Forfeiture of Founder Shares (in Shares) (575,000)      
Net income (loss) 8,916,352 8,916,352
Balance at Dec. 31, 2025 $ 95 $ 1,149 $ (16,382,885) $ (16,381,641)
Balance (in Shares) at Dec. 31, 2025 947,857 11,500,000      
[1] On November 26, 2024, the Company issued 40,000 Class A ordinary shares to each of its non-executive director nominees (160,000 Class A ordinary shares in total) in connection with their nomination as a director of the company. These issuances were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act (Note 7).
[2] Includes up to 1,575,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 7). On July 1, 2025, the Company issued additional 2,012,500 Class B ordinary shares to Sponsor in a share recapitalization, resulting in the total Class B ordinary shares outstanding increasing to 12,075,000. All share and per share amounts have been retrospectively restated (Note 4). On July 3, 2025, the underwriters partially exercised their over-allotment option. As a result of the partial exercise of the over-allotment option by the underwriters, 1,000,000 Founder Shares were no longer subject to forfeiture at such time. The remaining 575,000 Founder Shares were forfeited on August 17, 2025, the expiration date of the over-allotment option, as the over-allotment option remained unexercised, resulting in the total Class B ordinary shares outstanding decreasing to 11,500,000 (Note 4).